FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely, to psychiatry and neurology and can be used in the treatment of dementia with Lewy bodies, bipolar disorder and hypomania. The methods of the invention comprise administering to a subject in need of treatment a therapeutically effective amount of a compound of Formula (II)
.
EFFECT: use of inventions makes it possible to improve cognition, sleep, reduce negative symptoms with minimal side effects.
12 cl, 2 ex
| Title |
Year |
Author |
Number |
| METHODS OF USING CYCLIC AMIDE DERIVATIVES FOR TREATING SIGMA RECEPTOR MEDIATED DISORDERS |
2021 |
- Luthringer, Remy, Henri
- Pellegrini, Lorenzo
- Karabelas, Argeris, N.
|
RU2840025C2 |
| METHODS OF USING CYCLIC AMIDE DERIVATIVES FOR TREATING SIGMA-RECEPTOR MEDIATED DISORDERS |
2011 |
|
RU2613201C2 |
| METHODS FOR USING CYCLIC AMIDE DERIVATIVES FOR TREATING SCHIZOPHRENIA |
2011 |
- Lutringer Remi Anri
- Pellegrini Lorentso
- Karabelas Argeris N.
|
RU2576611C2 |
| MIXTURE CONTAINING CARBAMATE COMPOUND FOR PREVENTION, RELIEF OR TREATMENT OF SCHIZOPHRENIA |
2018 |
- Joung, Chan Mi
- Hwang, Sun Gwan
- Lee, Ji Won
- Jang, Young Koo
|
RU2772465C2 |
| NEW METHODS |
2014 |
- Vanover Kimberli
- Li Pen
- Mejts Sheron
- Devis Robert
- Uennogl Lourens P.
|
RU2682658C1 |
| THERAPEUTIC AGENTS |
2008 |
- Bilodo Mark T.
- Nanda Kausik K.
- Trotter B. Uehsli
|
RU2468025C2 |
| COMBINATIONS OF COMPOUNDS MODULATING THE NMDA RECEPTOR |
2015 |
|
RU2721948C2 |
| TREATMENT OF COGNITIVE DISORDERS WITH (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[B]THIOPHENE-2-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF |
2014 |
- Kenig Gerkhard
- Chesuort Richard
- Shapiro Gideon
|
RU2662560C2 |
| USING ROLUPERIDONE TO TREAT NEGATIVE SYMPTOMS AND DISEASES, INCREASE NEUROPLASTICITY AND PROMOTE NEUROPROTECTION |
2019 |
|
RU2812786C2 |
| THERAPEUTIC AGENT FOR TREATING NEUROLOGICAL BEHAVIOUR DISORDERS AND METHOD OF TREATING NEUROLOGICAL BEHAVIOUR DEVELOPMENT DISORDERS |
2011 |
|
RU2536230C2 |
